Patents by Inventor Todd Gac

Todd Gac has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9090584
    Abstract: The invention provides well-defined amides for treating glaucoma and ocular hypertension.
    Type: Grant
    Filed: January 21, 2011
    Date of Patent: July 28, 2015
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Todd Gac
  • Patent number: 8865766
    Abstract: Provided herein, inter alia, are prodrugs of bimatoprost, methods of using the same and compositions including the same.
    Type: Grant
    Filed: February 13, 2012
    Date of Patent: October 21, 2014
    Assignee: Allergan, Inc.
    Inventors: David F. Woodward, Jenny W. Wang, Neil J. Poloso, Todd Gac, Robert M. Burk, Michael E. Garst
  • Patent number: 8592413
    Abstract: Disclosed herein are compounds represented by a formula: Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: May 11, 2009
    Date of Patent: November 26, 2013
    Assignee: Allergan, Inc.
    Inventors: Todd Gac, David W. Old
  • Publication number: 20120295972
    Abstract: Provided herein, inter alia, are prodrugs of bimatoprost, methods of using the same and compositions including the same.
    Type: Application
    Filed: February 13, 2012
    Publication date: November 22, 2012
    Inventors: David F. Woodward, Jenny W. Wang, Neil J. Poloso, Todd Gac, Robert M. Burk, Michael E. Garst
  • Patent number: 8198318
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein G, E, B, Y, and A are as described. Methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: March 16, 2009
    Date of Patent: June 12, 2012
    Assignee: Allergen, Inc.
    Inventors: David W. Old, Robert M. Burk, Todd Gac
  • Publication number: 20110172299
    Abstract: Disclosed herein are compounds represented by a formula: Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: May 11, 2009
    Publication date: July 14, 2011
    Applicant: ALLERGAN, INC.
    Inventors: Todd Gac, David W. Old
  • Publication number: 20090247594
    Abstract: Disclosed herein is a compound having a structure or a pharmaceutically acceptable salt thereof, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: June 2, 2009
    Publication date: October 1, 2009
    Applicant: ALLERGAN, INC.
    Inventors: Robert M. Burk, David W. Old, Todd Gac
  • Publication number: 20090239858
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein G, E, B, Y, and A are as described. Methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: March 16, 2009
    Publication date: September 24, 2009
    Applicant: ALLERGAN, INC.
    Inventors: David W. Old, Robert M. Burk, Todd Gac
  • Patent number: 7557095
    Abstract: Disclosed herein is a compound having a structure or a pharmaceutically acceptable salt thereof, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: May 7, 2007
    Date of Patent: July 7, 2009
    Assignee: Allergan, Inc.
    Inventors: Robert M. Burk, David W. Old, Todd Gac
  • Publication number: 20080132543
    Abstract: A compound comprising a prodrug of a prostaglandin EP4 agonist, wherein said prodrug is an ester, ether, or amide of a carbohydrate; or said prodrug is an ester, ether, or amide of an amino acid is disclosed herein. Maintenance of the colonic mucosal barrier by method comprising administering a therapeutically effective amount of a prostaglandin EP4 agonist to a colon of a mammal is also disclosed herein. Dosage forms, medicaments, and compositions, related thereto are also disclosed.
    Type: Application
    Filed: October 24, 2005
    Publication date: June 5, 2008
    Inventors: Wha Bin Im, Yariv Donde, Mark Holoboski, David W. Old, Karen M. Kedzie, Daniel W. Gil, John E. Donello, Robert M. Burk, Todd Gac
  • Publication number: 20080119560
    Abstract: The compounds disclosed herein are useful for treating glaucoma, ocular hypertension, and baldness.
    Type: Application
    Filed: January 9, 2008
    Publication date: May 22, 2008
    Inventors: David Old, Todd Gac, Vinh Ngo
  • Publication number: 20080058414
    Abstract: Novel compounds, and therapeutic methods, compositions and medicament related thereto are disclosed herein.
    Type: Application
    Filed: January 10, 2006
    Publication date: March 6, 2008
    Applicant: Allergan, Inc.
    Inventors: David Old, Todd Gac, Vinh Ngo
  • Publication number: 20070265321
    Abstract: Disclosed herein is a compound having a structure or a pharmaceutically acceptable salt thereof, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: May 7, 2007
    Publication date: November 15, 2007
    Inventors: Robert M. Burk, David W. Old, Todd Gac
  • Publication number: 20070265464
    Abstract: Therapeutic compounds, methods, and compositions are disclosed herein.
    Type: Application
    Filed: January 4, 2007
    Publication date: November 15, 2007
    Inventors: David Old, Todd Gac, Vinh Ngo